Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Racial and Ethnic Disparities Among COVID-19 Cases in Workplace Outbreaks by Industry Sector - Utah, March 6-June 5, 2020.
Bui DP, McCaffrey K, Friedrichs M, LaCross N, Lewis NM, Sage K, Barbeau B, Vilven D, Rose C, Braby S, Willardson S, Carter A, Smoot C, Winquist A, Dunn A. Bui DP, et al. Among authors: sage k. MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1133-1138. doi: 10.15585/mmwr.mm6933e3. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32817604 Free PMC article.
Disparities in COVID-19 Incidence, Hospitalizations, and Testing, by Area-Level Deprivation - Utah, March 3-July 9, 2020.
Lewis NM, Friedrichs M, Wagstaff S, Sage K, LaCross N, Bui D, McCaffrey K, Barbeau B, George A, Rose C, Willardson S, Carter A, Smoot C, Nakashima A, Dunn A. Lewis NM, et al. Among authors: sage k. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1369-1373. doi: 10.15585/mmwr.mm6938a4. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32970656 Free PMC article.
E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury - Utah, April-October 2019.
Lewis N, McCaffrey K, Sage K, Cheng CJ, Green J, Goldstein L, Campbell H, Ferrell D, Malan N, LaCross N, Maldonado A, Board A, Hanchey A, Harris D, Callahan S, Aberegg S, Risk I, Willardson S, Carter A, Nakashima A, Duncan J, Burnett C, Atkinson-Dunn R, Dunn A. Lewis N, et al. Among authors: sage k. MMWR Morb Mortal Wkly Rep. 2019 Oct 25;68(42):953-956. doi: 10.15585/mmwr.mm6842e1. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31647788 Free PMC article.
Examining the temporality of vitamin E acetate in illicit THC-containing e-cigarette, or vaping, products from a public health and law enforcement response to EVALI - Utah, 2018-2020.
Arons MM, Barnes SR, Cheng R, Whittle K, Elsholz C, Bui D, Gilley S, Maldonado A, LaCross N, Sage K, Lewis N, McCaffrey K, Green J, Duncan J, Dunn AC. Arons MM, et al. Among authors: sage k. Int J Drug Policy. 2021 Feb;88:103026. doi: 10.1016/j.drugpo.2020.103026. Epub 2020 Nov 24. Int J Drug Policy. 2021. PMID: 33246266
Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021.
Rao AK, Schulte J, Chen TH, Hughes CM, Davidson W, Neff JM, Markarian M, Delea KC, Wada S, Liddell A, Alexander S, Sunshine B, Huang P, Honza HT, Rey A, Monroe B, Doty J, Christensen B, Delaney L, Massey J, Waltenburg M, Schrodt CA, Kuhar D, Satheshkumar PS, Kondas A, Li Y, Wilkins K, Sage KM, Yu Y, Yu P, Feldpausch A, McQuiston J, Damon IK, McCollum AM; July 2021 Monkeypox Response Team. Rao AK, et al. Among authors: sage km. MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):509-516. doi: 10.15585/mmwr.mm7114a1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35389974 Free PMC article.
Consent-Related Outcomes in the Alteplase Compared to Tenecteplase Trial.
Shamy MC, Dewar B, Deschaintre Y, Singh N, Kenney C, Almekhlafi MA, Ademola A, Buck BH, Sajobi TT, Catanese L, Sage KD, Dowlatshahi D, Gioia LC, Tkach A, Swartz RH, Menon BK. Shamy MC, et al. Among authors: sage kd. Neurology. 2024 Nov 26;103(10):e209974. doi: 10.1212/WNL.0000000000209974. Epub 2024 Nov 7. Neurology. 2024. PMID: 39509663 Clinical Trial.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell BCV, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 Jun 15;403(10444):2597-2605. doi: 10.1016/S0140-6736(24)00921-8. Epub 2024 May 17. Lancet. 2024. PMID: 38768626 Clinical Trial.
109 results